| Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism |
119 |
| Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae |
60 |
| The Super-Donor Phenomenon in Fecal Microbiota Transplantation |
57 |
| The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance |
40 |
| Back to the Future: Lessons Learned From the 1918 Influenza Pandemic |
38 |
| Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles |
36 |
| Mycotoxin: Its Impact on Gut Health and Microbiota |
35 |
| Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects |
34 |
| Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance? |
32 |
| Microglial Cells: The Main HIV-1 Reservoir in the Brain |
29 |
| Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy |
29 |
| How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication |
29 |
| The Pseudomonas Quinolone Signal (PQS): Not Just for Quorum Sensing Anymore |
28 |
| The Healthy Human Blood Microbiome: Fact or Fiction? |
26 |
| Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China |
24 |
| Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies |
24 |
| Effects of Metabolites Derived From Gut Microbiota and Hosts on Pathogens |
23 |
| ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis) |
23 |
| Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition |
23 |
| Relapsing Fevers: Neglected Tick-Borne Diseases |
23 |
| Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice |
23 |
| Molecular Targets Related Drug Resistance Mechanisms in MDR XDR and TDR-Mycobacterium tuberculosis Strains |
20 |
| Moderate Dietary Protein Restriction Optimized Gut Microbiota and Mucosal Barrier in Growing Pig Model |
19 |
| Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease |
19 |
| Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing |
19 |
| Metazoan Parasite Vaccines: Present Status and Future Prospects |
18 |
| The Role of Host Cholesterol During Flavivirus Infection |
18 |
| Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut |
17 |
| Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy |
17 |
| Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens |
17 |
| The Subgingival Microbiome of Periodontal Pockets With Different Probing Depths in Chronic and Aggressive Periodontitis: A Pilot Study |
17 |
| Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs |
17 |
| Mutation of Agr Is Associated with the Adaptation of Staphylococcus aureus to the Host during Chronic Osteomyelitis |
17 |
| Altered Gut Microbiota in Chinese Children With Autism Spectrum Disorders |
16 |
| Characteristics of Gut Microbiota in Patients With Rheumatoid Arthritis in Shanghai, China |
16 |
| Salmonella Pathogenicity Island 1 (SPI-1) and Its Complex Regulatory Network |
16 |
| Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C-difficile Infection |
16 |
| Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases? |
16 |
| Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time |
16 |
| Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women |
15 |
| Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment |
15 |
| Mycobacterium tuberculosis Virulent Factor ESAT-6 Drives Macrophage Differentiation Toward the Pro-inflammatory M1 Phenotype and Subsequently Switches It to the Anti-inflammatory M2 Phenotype |
15 |
| Dysbiosis of the Gut Microbiome in Lung Cancer |
15 |
| The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation |
15 |
| Association Between Gut Microbiota and Helicobacter pylori-Related Gastric Lesions in a High-Risk Population of Gastric Cancer |
15 |
| Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs |
15 |
| gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK |
14 |
| The LuxS/AI-2 Quorum-Sensing System of Streptococcus pneumoniae Is Required to Cause Disease, and to Regulate Virulence- and Metabolism-Related Genes in a Rat Model of Middle Ear Infection |
14 |
| Differential Regulation of the Phenazine Biosynthetic Operons by Quorum Sensing in Pseudomonas aeruginosa PAO1-N |
14 |
| Integration of Transcriptomic and Proteomic Approaches Reveals the Temperature-Dependent Virulence of Pseudomonas plecoglossicida |
14 |
